Lexaria Bioscience Corp. is a biotechnology company that employs a patented drug delivery technology called DehydraTECH to improve oral delivery of active pharmaceutical ingredients. With significant advantages in bio-absorption and time of onset, DehydraTECH is effective for administering cannabinoids, nicotine, and other drugs, and may even cross the blood brain barrier. The company maintains a research laboratory and possesses an extensive intellectual property portfolio covering 23 granted patents and around 50 pending patents across the globe.